MTOR and hepatocellular carcinoma: Specifically, diacylglycerols (DAGs) were shown to activate AKT which then in turn would activate AR (Figure 3D) demonstrating a further linkage between the AKT/mTOR pathway and AR in non-alcoholic fatty liver disease-mediated HCC.